Expression of ribonucleoside reductase subunit M1, but not excision repair crosscomplementation group 1, is predictive in muscleinvasive bladder cancer treated with chemotherapy and radiation

Author：        

Publisher： Spandidos Publications

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.2, Iss.3, 2014-01, pp. : 479-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

ERCC1 and XRCC1 expression predicts survival in bladder cancer patients receiving combined trimodality therapy

By Sakano   Ogawa   Yamamoto   Nishijima   Miyachika   Matsumoto   Hara   Matsuyama  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 403-410

Spandidos Publications

Access to resources Recommend Favorite

Thymosin 1 in combination with cytokines and chemotherapy for the treatment of cancer

By Garaci E.   Pica F.   Sinibaldi-Vallebona P.   Pierimarchi P.   Mastino A.   Matteucci C.   Rasi G.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1145-1150

Elsevier

Access to resources Recommend Favorite

Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies

By  

Current Molecular Medicine, Vol. 11, Iss. 8, 2011-11 ,pp. : 623-632

Bentham Science Publishers

Access to resources Recommend Favorite

Clinicopathological and prognostic significance of the microRNA processing enzyme DICER1 mRNA expression in colorectal cancer patients

By Akahane  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 267-273

Spandidos Publications

Access to resources Recommend Favorite

High expression of heat shock protein 105 predicts a favorable prognosis for patients with urinary bladder cancer treated with radical cystectomy

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 38-42

Spandidos Publications

Access to resources Recommend Favorite